Advanced search
Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 47, 2023 - Issue 6
Submit an article Journal homepage
56
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Adherence to Iron Chelation Therapy Among Children with Beta Thalassemia Major: A Multicenter Cross-Sectional Study

Thamron Keowmania Pharmacy Department, Hospital Wanita Dan Kanak-Kanak Sabah, Sabah, MalaysiaCorrespondence[email protected]
View further author information
,
Siew Chin Teoa Pharmacy Department, Hospital Wanita Dan Kanak-Kanak Sabah, Sabah, MalaysiaView further author information
,
Kuan Chau Yapb Pharmacy Department, Hospital Tunku Azizah, Kuala Lumpur, MalaysiaView further author information
,
Wei Lian Chuac Pharmacy Department, Hospital Raja Perempuan Zainab II, Kelantan, MalaysiaView further author information
,
Nur Farahanim Mohd Tahird Pharmacy Department, Hospital Melaka, Melaka, MalaysiaView further author information
,
Peck Wei Chuae Pharmacy Department, Hospital Tengku Ampuan Afzan, Pahang, MalaysiaView further author information
,
V Co Limf Pharmacy Department, Hospital Ampang, Selangor, MalaysiaView further author information
&
Hoon Hing Leongg Pharmacy Department, Hospital Queen Elizabeth, Sabah, MalaysiaView further author information
 show all
Pages 237-244 | Received 12 May 2023, Accepted 09 Dec 2023, Published online: 18 Dec 2023

References

  • Ibrahim HM, Muda Z, Othman IS, et al. Observational study on the current status of thalassaemia in Malaysia: a report from the Malaysian Thalassaemia Registry. BMJ Open. 2020;10(6):e037974. doi: 10.1136/bmjopen-2020-037974.
  • Annual Report of the Malaysian Thalassaemia Registry 2019 [Internet]. [cited 2023 Feb15]. Available from: https://www.moh.gov.my/moh/resources/Penerbitan/Laporan/Umum/Annual_Report_of_the_Malaysian_Thalassaemia_Registry_2019.pdf
  • Pedram M, Zandian K, Keikhaie B, et al. A report on chelating therapy and patient compliance by determination of serum ferritin levels in 243 thalassemia major patients. J Compr Pediatr. 2010;2(2):65–69.
  • Sheth S. Iron chelation: an update. Curr Opin Hematol. 2014; 21(3):179–185. doi: 10.1097/MOH.0000000000000031.
  • Management of Transfusion Dependent Thalassaemia. [Internet]. [cited 2023 Feb18]. Available from: https://www3.moh.gov.my/moh/attachments/8318.pdf.
  • Brown LD, Cai TT, DasGupta A. Interval estimation for a binomial proportion. Statist Sci. 2001;16(2):101–133. doi: 10.1214/ss/1009213286.
  • Ismail HIHM, Ibrahim HM, Ng HP, et al. Paediatric protocols for Malaysian hospitals. 4th ed. Putrajaya (MY): Malaysia Paediatric Association; 2019.
  • Thalassaemia: Modul Thalassaemia. [Internet]. [cited 2023 Feb17]. Available from: https://www.infosihat.gov.my/penerbitan-multimedia/lain-lain/item/thalassaemia-modul-thalassaemia.html.
  • Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497. doi: 10.1056/NEJMra050100.
  • Reddy PS, Locke M, Badawy SM. A systematic review of adherence to iron chelation therapy among children and adolescents with thalassemia. Ann Med. 2022;54(1):326–342. doi: 10.1080/07853890.2022.2028894.
  • Aina Mariana AM, Yap SH. Management and clinical outcome of children with transfusion-dependent thalassaemia in hospital Tuanku Ja’afar Seremban. Med J Malaysia. 2014;69(4):178–183.
  • Lee WS, Toh TH, Chai PF, et al. Self-reported level of and factors influencing the compliance to desferrioxamine therapy in multitransfused thalassaemias. J Paediatr Child Health. 2011;47(8):535–540. doi: 10.1111/j.1440-1754.2011.02017.x.
  • Mohamed R, Rahman AH, Masra F, et al. Barriers to adherence to iron chelation therapy among adolescent with transfusion dependent thalassemia. Front Pediatr. 2022;10:951947. doi: 10.3389/fped.2022.951947.
  • Elalfy MS, Adly AM, Wali Y, et al. Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients. Eur J Haematol. 2015;95(5):411–420. doi: 10.1111/ejh.12507.
  • Taher A, Al Jefri A, Elalfy MS, et al. Improved treatment satisfaction and convenience with deferasirox in iron-overloaded patients with β-thalassemia: results from the ESCALATOR trial. Acta Haematol. 2010;123(4):220–225. doi: 10.1159/000313447.
  • Lee YL, Lin DT, Tsai SF. Disease knowledge and treatment adherence among patients with thalassemia major and their mothers in Taiwan. J Clin Nurs. 2009;18(4):529–538. doi: 10.1111/j.1365-2702.2007.02150.x.
  • Al-Kloub MI, Nayel Salameh T, Froelicher ES. Impact of psychosocial status and disease knowledge on deferoxamine adherence among thalassaemia major adolescents. Int J Nurs Pract. 2014;20(3):265–274. doi: 10.1111/ijn.12143.
  • Delea TE, Edelsberg J, Sofrygin O, et al. Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. Transfusion. 2007;47(10):1919–1929. doi: 10.1111/j.1537-2995.2007.01416.x.
  • Bryson SP. Patient-centred, administration friendly medicines for children–An evaluation of children’s preferences and how they impact medication adherence. Int J Pharm. 2014;469(2):257–259. doi: 10.1016/j.ijpharm.2014.04.069.
  • Diddi S, Author C, Lustig J, et al. FILM-COATED TABLETS (deferasirox) Malaysian Package Leaflet [Internet]. [cited 2023 Nov 25]. Available from: https://quest3plus.bpfk.gov.my/front-end/attachment/17050/pharma/79821/V_59934_20211108_151130_D3.pdf.
  • Yassin MA, Soliman AT, De Sanctis V, et al. Jadenu® substituting Exjade® in iron overloaded β-thalassemia major (BTM) patients: a preliminary report of the effects on the tolerability, serum ferritin level, liver iron concentration and biochemical profiles. Mediterr J Hematol Infect Dis. 2018;10(1):e2018064. doi: 10.4084/MJHID.2018.064.
  • Badawy SM, Kattamis A, Ezzat H, et al. The safety and acceptability of twice-daily deferiprone for transfusional iron overload: a multicentre, open-label, phase 2 study. Br J Haematol. 2022;197(1):e12-5–e15. doi: 10.1111/bjh.17999.
  • Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129(1):125–137. doi: 10.1093/oxfordjournals.aje.a115101.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.